These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14552557)

  • 21. [The role of corticotropin-releasing hormone in alteration of adaptive behavior of the active and passive rats after inescapable stress].
    Shaliapina VG; Rakitskaia VV; Petrova EI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2005; 55(2):241-6. PubMed ID: 15895866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential behavioural effects after subtotal depletions of dopamine or noradrenaline in the ventral striatum.
    Schwarting RK; Carey RJ
    Funct Neurol; 1988; 3(1):29-36. PubMed ID: 3134274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of dopamine, norepinephrine and 5-hydroxytryptamine in different regions of the rat brain in thallium toxicosis.
    Hasan M; Ali SF; Tariq M
    Acta Pharmacol Toxicol (Copenh); 1978 Sep; 43(3):169-73. PubMed ID: 707129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies of intracerebroventricularly administered cysteamine and pantethine in different behavioral tests and on brain catecholamines in rats.
    Vécsei L; Alling C; Widerlöv E
    Arch Int Pharmacodyn Ther; 1990; 305():140-51. PubMed ID: 2241425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum.
    Sorg BA; Kalivas PW
    Brain Res; 1991 Sep; 559(1):29-36. PubMed ID: 1782559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus.
    Brunetti L; Ferrante C; Orlando G; Recinella L; Leone S; Chiavaroli A; Di Nisio C; Shohreh R; Manippa F; Ricciuti A; Mollica A; Vacca M
    Peptides; 2013 Oct; 48():83-8. PubMed ID: 23916912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of taurine, homotaurine and GABA on hypothalamic and striatal dopamine metabolism.
    Panula-Lehto E; Mäkinen M; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):57-62. PubMed ID: 1407006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bombesin increases dopamine function in rat brain areas.
    Widerlöv E; Mueller RA; Frye GD; Breese GR
    Peptides; 1984; 5(3):523-8. PubMed ID: 6433330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central and peripheral effects of iminodipropionitrile on catecholamine metabolism in rats.
    Cadet JL; Karoum F
    Synapse; 1988; 2(1):23-7. PubMed ID: 3420528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vitamin B-6 nutrition on the levels of dopamine, dopamine metabolites, dopa decarboxylase activity, tyrosine, and GABA in the developing rat corpus striatum.
    Guilarte TR
    Neurochem Res; 1989 Jun; 14(6):571-8. PubMed ID: 2761676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine synthesis in inbred mouse strains which differ in numbers of dopamine neurons.
    Sved AF; Baker HA; Reis DJ
    Brain Res; 1984 Jun; 303(2):261-6. PubMed ID: 6744023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Catecholamine content of the rat brain at different stages of experimental alcoholism].
    Varkov AI; Malikova LA
    Biull Eksp Biol Med; 1985 Mar; 99(3):316-7. PubMed ID: 4039198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Endorphin alters dopamine uptake by the dopamine neurons of the hypothalamus and striatum.
    George SR; Van Loon GR
    Brain Res; 1982 Sep; 248(2):293-303. PubMed ID: 6291701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat.
    Vécsei L; Ekman R; Alling C; Widerlöv E
    J Neural Transm Gen Sect; 1989; 78(3):209-20. PubMed ID: 2572245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the striatum in the central regulation of the hormonal functions of the gonads.
    Rybnikova EA; Rakitskaya VV; Shalyapina VG
    Neurosci Behav Physiol; 2000; 30(5):565-7. PubMed ID: 11037149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterosis for concentrations of dopamine, norepinephrine, their metabolites, and epinephrine in the chick hyperstriatum ventrale, hypothalamus, and optic tectum.
    Barbato GF; Kruzelock RP
    Behav Genet; 1992 May; 22(3):381-98. PubMed ID: 1616467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in nigrostriatal dopaminergic function within BDNF mutant mice.
    Dluzen DE; Story GM; Xu K; Kucera J; Walro JM
    Exp Neurol; 1999 Dec; 160(2):500-7. PubMed ID: 10619567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamics of hypothalamic CRH immune reactivity in active and passive rats in the course of development of behavioural depression].
    Mironova VI; Rybnikova EA; Rakitskaia VV; Shaliapina VG
    Ross Fiziol Zh Im I M Sechenova; 2004 Sep; 90(9):1161-9. PubMed ID: 15559792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats.
    Suemaru S; Hashimoto K; Ota Z
    Acta Med Okayama; 1985 Dec; 39(6):463-70. PubMed ID: 3004111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.